NCT06337708 Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
| NCT ID | NCT06337708 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Arizona State University |
| Condition | Physical Activity |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2024-04-08 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 240 participants in total. It began in 2024-04-08 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.
Eligibility Criteria
Inclusion Criteria: * Self-reported African American/Black female * Aged of 24-65 years * Insufficiently Active (\< 60 minutes of moderate-to-vigorous physical activity per week as measured by Exercise Vital Sign Questionnaire) * BMI \> 30 kg/m2 * English speaking and reading * Ownership of a smartphone with the ability to download applications (i.e., apps) * Ownership of a smartphone with the ability to receive text messages * Willingness to receive a physical activity intervention delivered through their smartphone * Willingness to include their first name or create an alias to be used on their profile page on the Smart Walk app Exclusion Criteria: * Plans to relocate out of Phoenix area in next 12 months * Endorsing an item on the Physical Activity Readiness Questionnaire (PAR-Q), unless a doctor's note for study participation in provided * Resting systolic blood pressure greater than 180 mmHG and/or a diastolic blood pressure greater than 120 mmHG , as assessed at baseline or at any other study assessment * Self-reported participation in another diet or weight loss study at screening * Pregnant or planning to become pregnant in the next 12 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06337708 clinical trial?
This trial is open to female participants only, aged 24 Years or older, up to 65 Years, studying Physical Activity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06337708 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT06337708 currently recruiting?
Yes, NCT06337708 is actively recruiting participants. Contact the research team at rodney.joseph@asu.edu for enrollment information.
Where is the NCT06337708 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT06337708 clinical trial?
NCT06337708 is sponsored by Arizona State University. The trial plans to enroll 240 participants.